Publications by authors named "Samuel A Funt"

26Publications

Reply to L.H. Einhorn et al.

J Clin Oncol 2020 Sep 7;38(26):3074-3075. Epub 2020 Jul 7.

Deaglan McHugh, MD, Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center and Department of Medicine, Weill Medical College of Cornell University, New York, NY; George J. Bosl, MD, Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; and Samuel A. Funt, MD and Darren R. Feldman, MD, Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, and Department of Medicine, Weill Medical College of Cornell University, New York, NY.

View Article and Find Full Text PDF
September 2020

Impact of Teratoma on the Cumulative Incidence of Disease-Related Death in Patients With Advanced Germ Cell Tumors.

J Clin Oncol 2019 09 24;37(26):2329-2337. Epub 2019 Jun 24.

Memorial Sloan Kettering Cancer Center, New York, NY and Weill Cornell Medical College, New York, NY.

View Article and Find Full Text PDF
September 2019

A New Twist to an Old Tale: Immunotherapy in Non-muscle-invasive Bladder Cancer.

Eur Urol Oncol 2018 08 24;1(3):199-201. Epub 2018 Jul 24.

Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.

View Article and Find Full Text PDF
August 2018

The Cancer Immunogram as a Framework for Personalized Immunotherapy in Urothelial Cancer.

Eur Urol 2019 03 28;75(3):435-444. Epub 2018 Sep 28.

Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address:

View Article and Find Full Text PDF
March 2019

Global Cancer Transcriptome Quantifies Repeat Element Polarization between Immunotherapy Responsive and T Cell Suppressive Classes.

Cell Rep 2018 Apr;23(2):512-521

Tisch Cancer Institute, Departments of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Oncological Sciences and Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Precision Immunology Institute at the Icahn School of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address:

View Article and Find Full Text PDF
April 2018

Controversies in the Management of Clinical Stage I Seminoma: Carboplatin a Decade in-Time to Start Backing Out.

J Clin Oncol 2018 03 1;36(9):837-840. Epub 2018 Feb 1.

Rune A.W. van de Wetering and Stefan Sleijfer, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands; Darren R. Feldman, Samuel A. Funt, and George J. Bosl, Memorial Sloan Kettering Cancer Center, New York, NY; and Ronald de Wit, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands.

View Article and Find Full Text PDF
March 2018

Efficacy and toxicity of therapy immediately after treatment with nivolumab in relapsed multiple myeloma.

Leuk Lymphoma 2018 01 30;59(1):221-224. Epub 2017 May 30.

a Department of Medicine , Memorial Sloan Kettering Cancer Center, Weill Cornell Medical Center , New York , NY , USA.

View Article and Find Full Text PDF
January 2018

Systemic, perioperative management of muscle-invasive bladder cancer and future horizons.

Nat Rev Clin Oncol 2017 04 22;14(4):221-234. Epub 2016 Nov 22.

Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA.

View Article and Find Full Text PDF
April 2017